The purpose of this task order is the development and delivery of a quality assurance/quality control (QA/QC) plan and participation in the task order initiation meeting.
Ended Awarded Last action
- Contract number
- 75N93021F00002
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,640
Award facts
- Opportunity
-
- Preclinical Services for HIV Therapeutics Pre-Solicitation · 75N93021F00002 · Posted Oct 4, 2019
- Contract value 100% obligated
- $12,640.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$11,751 | |
| Original award | $24,391 |
About this award
The Southern Research Institute has been awarded a $12,640.21 delivery order against the Preclinical Services for HIV Therapeutics master IDIQ contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this cost-plus-fixed-fee task order, Southern Research will develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services for HIV therapeutics. The work will be performed in Birmingham, Alabama over a thirty-three month period concluding in December 2023. No subcontractors or set-aside designations were indicated. The National Institute of Allergy and Infectious Diseases funds research to better understand, treat, and prevent infectious and immune-mediated diseases.
Quick answers
Who was awarded contract 75N93021F00002?
75N93021F00002 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2021.
How much is contract 75N93021F00002 worth?
The government has obligated $12,640 on 75N93021F00002.
Is contract 75N93021F00002 an order under another contract?
Yes. 75N93021F00002 is a delivery order under 75N93021D00010, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93021F00002 competed?
The extent of competition for 75N93021F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award